Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Cutaneous Lymphomas
Questions discussed in this category
When is mechlorethamine better than more common treatments like light therapy and topical steroids for mycosis fungoides?
3 Answers available
How often do you pursue malignant transformation screening In patients with lymphomatoid papulosis or pityriasis lichenoides?
And what workup do you pursue?
1 Answer available
How do you approach balancing the potential risk of worsening actinic damage and maintaining CTCL clearance in patients treated with nb-UVB?
2 Answers available
How do you approach screening for additional malignancies in patients with a history of CTCL?
There have been reports suggesting that patients with CTCL may be at increased risk for other malignancies.
2 Answers available
What first-line therapies do you recommend for patients with folliculotropic mycosis fungoides?
Has topical dapsone worked?
3 Answers available
Do you hold histone deacetylase (HDAC) inhibitors for patients receiving palliative radiation therapy for cutaneous lymphomas?
If so, how long before/after radiation?
1 Answer available
When should you discontinue narrow band UVB when a patient is in clinical remission from patch stage mycosis fungoides?
3 Answers available
How do you differentiate erythrodermic mycosis fungoides and Sezary syndrome - is it primarily based on the burden of blood involvement of malignant cells?
Mycosis fungoides and Sezary syndrome are thought to be distinct genotypically and phenotypically. It is my understanding that Sezary syndrome typical...
2 Answers available
16697
20196
15453
11698
14344
14126
13860
12761
Related Topics
Dermatology
Hematologic Malignancies
Medical Oncology
Radiation Oncology
Internal Medicine
Hematology